SNP Lab (CEO Jaeyoung Lee), a data platform company based on personal information protection, participated in the European technology startup fair 'VivaTech 2025' held in Paris, France from June 11th to 14th and introduced the mydata transaction platform 'my:D' to the global market.
'VivaTech', now in its 9th year, is a representative tech exhibition in Europe, with over 14,000 startups and global companies from around the world, and approximately 180,000 visitors. As part of the Korea-Japan Open Innovation Linkage Program, SNP Lab has laid the foundation for entering the European market by conducting various activities such as exhibitions, networking, and investor meetings.
During the event, SNP Lab introduced the potential of the individual-led MyData ecosystem to local visitors and investors, while discussing collaboration opportunities with Dassault Systèmes and seeking practical ways to cooperate for global business expansion. Through the 'Korea-France Open Innovation Week' program, a technology meeting was held in connection with Dassault Systèmes' genome electronic lab notebook system, and discussions were also held on joint technology development.
In addition, SNP Lab was selected as the final partner company for the 2025 global corporate collaboration program 'Daonda', and was recognized for both its technological prowess and global business potential. Based on this, it plans to build a trust-based data platform that can safely analyze and utilize sensitive information, including unstructured data, by utilizing Dassault Systèmes' solutions. In addition, it plans to continue to advance its services targeting overseas markets by establishing a system that can respond to international regulations, such as the European Union's (EU) personal information protection regulation, GDPR.
SNP Lab CEO Jaeyoung Lee said, “Through our participation in VivaTech, we have confirmed the high interest and demand for MyData utilization in the European market,” and added, “We will continue to strengthen our global technology partnerships and focus on research and development to provide competitive global services in the fields of AI-based hyper-personalized healthcare and B2B MyData platforms.”
- See more related articles
You must be logged in to post a comment.